The 10th Circuit on Monday overturned a $43 million judgment, finding that Boeing subsidiary Jeppesen Sanderson does not owe Massachusetts-based software company SolidFX the money for lost profits. Jeppesen Sanderson, which creates terminal charts for Boeing pilots, asked SolidFX in 2008 to develop an electronic app that would act as an e-reader for Jeppesen data for pilots.
After negotiating a licensing agreement, SolidFX began selling the iRex devices that came embedded with Jeppesen’s data on a platform created by SolidFX. After Apple released its iPad in 2010, SolidFX asked Jeppesen for the toolkit used in the app, to adapt it for the iPad. Jeppesen refused.
Months later, Jeppesen announced that it had created its own iPad app, free for its terminal chart users.
SolidFX sued Jeppesen in Colorado Federal Court on breach of contract and antitrust charges, claiming that Jeppesen had concealed its own development of the iPad app.
US District Judge William J. Martinez presided over an eight-day trial in April 2014, in which a jury awarded SolidFX $43 million in lost profits due to Jeppesen’s breach of contract. But the trial court rejected SolidFX’s antitrust claims, finding that Jeppesen had simply exercised its right to refuse to license copyrighted work.
Jeppesen appealed the $43 million award, claiming SolidFX could not recover lost profits from its contract claims because the licensing agreement expressly prohibited it. SolidFX cross-appealed on its antitrust claim, saying Jeppesen illegally monopolized the product SolidFX and Jeppesen created together.
Full Content: Courthouse News
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas